Shanghai Zhongshan Hospital

This study is testing whether adding a new antibody drug called HLX22 to the standard treatment (trastuzumab plus chemotherapy) works better for people with a specific type of metastatic pancreatic cancer that tests positive for HER2. It will involve about 45 adults who have not …

This early-stage study is testing a new approach to treat diabetes. Doctors will take a small sample of a patient's own pancreatic tissue, grow special cells from it in a lab, and then transplant those cells back into the patient. The goal is to see if these transplanted cells ca…

This study is testing a new combination of two drugs, candonilimab and LM-302, for people with advanced bile duct cancer that has continued to grow despite standard chemotherapy and immunotherapy. The goal is to see if this combination can shrink tumors and control the disease fo…

This study is testing a new three-drug combination given before surgery for a type of aggressive liver cancer called intrahepatic cholangiocarcinoma. The goal is to shrink tumors and lower the very high chance of the cancer coming back after surgery. Researchers will compare this…